期刊文献+

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers 被引量:1

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
下载PDF
导出
摘要 To The Editor I want to congratulate Dr.Tan and colleagues for their article entitled'Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer:a randomized controlled trial'[1].The pathologic complete response(pCR)rate was similar in the two arms(10.61%vs.12.31%,P=0.665).However,the To The Editor I want to congratulate Dr.Tan and colleagues for their article entitled"Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer:a randomized controlled trial"[1].The pathologic complete response(pCR)rate was similar in the two arms(10.61%vs.12.31%,P=0.665).
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2017年第6期282-283,共2页
  • 相关文献

参考文献1

二级参考文献3

同被引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部